Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 9,050 Castle Biosciences, Inc. shares (Form 4)

Traded Aug 25, 2026 · Filed Aug 27, 2026

On Aug 25, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 9,050 Castle Biosciences, Inc. shares at US$35.04 for US$317K under a trading plan, leaving 66,914 shares. Filed Aug 27, 2026 (Form 4).

Sold
9,050 shares
Price
US$35.04
Value
US$317K
Holding after
66,914 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 25, 2026Common StockSale9,050US$35.0466,914Direct

Source

View original at SEC

Related